CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer

Name: CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer
License: Public Domain

Kunming Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non-small-cell-lung-cancer

non-small cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 160367
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.